Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05342194
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-08-15
First Post:
2022-04-07
Brief Title:
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC a Phase III Study
Sponsor:
Shanghai Junshi Bioscience Co Ltd
Organization:
Shanghai Junshi Bioscience Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-07
First Submit QC Date:
April 15 2022
Study First Post Date:
2022-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-12
Last Update Post Date:
2022-08-15
Last Update Post Date Type:
ACTUAL